Skip to content

Lobbying by Group Jamp Pharma: its registrations, its lobbyists, the bills it has named and every meeting it has reported with federal office holders since November 2021.

← Lobbying

Client of a consultant lobbyist

Group Jamp Pharma

Meetings this Parliament
2
With MPs
0
Since Nov 2021
2
Active registrations
1

Most recent reported meeting: Aug 5, 2026.

Who they meet

Since the current Parliament opened.

Institutions

  • Office of the Quebec Lieutenant1
  • Innovation, Science and Economic Development Canada (ISED)1

Registrations in effect

Consultant In effect since Aug 11, 2026

Consultant Sophie Anne Lévesque of TACT - Intelligence conseil

Consultant lobbyists

  • Sophie Anne Lévesque Former public office holder

    Formerly Directrice du bureau de circonsription, Bureau du membre du parlement Pascale St-Onge, Chambre des communes (2022–2025)

Institutions they may lobby: Finance Canada (FIN), Health Canada (HC), House of Commons, Innovation, Science and Economic Development Canada (ISED), Office of the Quebec Lieutenant, Prime Minister's Office (PMO)

What they're lobbying on (1)
  • Démarches visant à renforcer l'autonomie pharmaceutique au Canada, dans le contexte de la modernisation réglementaire suivant les consultations sur les initiatives visant à réduire le fardeau administratif pour faciliter l’accès aux médicaments.

Registration 965020-387412-2. Look it up in the official Registry

Reported meetings

Spreadsheet

  • Reported by Sophie Anne Lévesque · Consultant

    • Djamel Boumenna · Conseiller principal, Office of the Quebec Lieutenant
    Démarches visant à renforcer l'autonomie pharmaceutique au Canada, dans le contexte de la modernisation réglementaire suivant les consultations sur les initiatives visant à réduire le fardeau administratif pour faciliter l’accès aux médicaments. Read more

    Official report

  • Reported by Sophie Anne Lévesque · Consultant

    • Cyril Nawar · Conseiller régional pour le Québec, Innovation, Science and Economic Development Canada (ISED)
    Démarches visant à renforcer l'autonomie pharmaceutique au Canada, dans le contexte de la modernisation réglementaire suivant les consultations sur les initiatives visant à réduire le fardeau administratif pour faciliter l’accès aux médicaments. Read more

    Official report

From the Office of the Commissioner of Lobbying's open data, published November 5, 2026. Reports cover oral, arranged meetings with designated public office holders since November 22, 2021; lobbyists file them by the 15th of the following month. Names of MPs are matched to the current House of Commons, and bills are linked when the lobbyist's own description makes clear which bill it means. Contains information licensed under the Open Data Licence Agreement — Office of the Commissioner of Lobbying. Licence. PolitiKit is independent and is not endorsed by the Commissioner of Lobbying.